co.don AG

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between November 18 and November 24, 2016,

Company Changes BRENNEMAN , Ryan R. To: EyeGate Pharmaceuticals Inc. , CFO (April) From: CYS Investments Inc., SVP, Chief Accounting Officer Phone: 781-788-9043 CHEN , Jiayu, PhD To: Gyneso

Regenerating the hyaline cartilage found in the knee is one of the most elusive and highly sought after goals facing researchers in the orthopedic industry today. ( See Also see " Knee OA: Growing Dem